(Hypertension. 1999;34:107-112.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Hypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Correspondence to Frans H.H. Leenen, MD, PhD, FRCPC, Hypertension Unit, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario, Canada K1Y 4W7. E-mail fleenen{at}ottawaheart.ca
AbstractIn Dahl salt-sensitive
rats on a high salt diet or normotensive rats with chronic central
infusion of sodium, increased brain "ouabain" results in
sympathetic hyperactivity and hypertension, possibly by activating the
brain renin-angiotensin system. In the present study,
we tested whether the hypertension caused by exogenous ouabain also
depends on activation of brain renin-angiotensin system. In
Wistar rats, ouabain (50 µg/d) was infused subcutaneously for 14 days
with the use of osmotic minipumps. Concomitantly, in one group, the
angiotensin II type 1 receptor blocker losartan (1
mg/kg per day) was infused
intracerebroventricularly. On day 15,
mean arterial pressure, heart rate, central venous
pressure, and renal sympathetic nerve activity were recorded in
conscious rats at rest and in response to air-jet stress,
intracerebroventricular injection of
the
2-agonist guanabenz (25 and 75 µg) or
angiotensin II (30 ng), acute volume expansion, and ramp
changes of blood pressure by ±50 mm Hg with
phenylephrine and nitroprusside. Compared with control
rats, in rats treated with ouabain, resting mean arterial
pressure was significantly increased (111±4 versus 93±3 mm Hg;
P<0.05), and increases or decreases in mean
arterial pressure, heart rate, and renal sympathetic nerve
activity in response to air stress or guanabenz were enhanced
significantly. These effects of ouabain were prevented when
losartan was given concomitantly. Maximal slopes of
arterial baroreflex control of renal sympathetic nerve
activity and heart rate tended to be decreased in ouabain-treated
versus control rats and were significantly increased in ouabain-treated
rats with versus without losartan. No differences in
cardiopulmonary baroreflex function were detected. It seems
that by day 14 to 15, the central effect of ouabain on baroreflex
control prevails over its peripheral sensitizing effect on
baroreceptors, leading to a tendency of desensitization. These results
indicate that chronic administration of ouabain activates the
brain renin-angiotensin system, resulting in decreased
sympathoinhibition and increased sympathoexcitation, impairment of
baroreflex function, and hypertension.
Key Words: baroreflex renal nerves stress, air-jet guanabenz renin-angiotensin system
This article has been cited by other articles:
![]() |
W. J. Cheung, M.-A. H. Kent, E. El-Shahat, H. Wang, J. Tan, R. White, and F. H. H. Leenen Central and peripheral renin-angiotensin systems in ouabain-induced hypertension Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H624 - H630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Briones, F. E. Xavier, S. M. Arribas, M. C. Gonzalez, L. V. Rossoni, M. J. Alonso, and M. Salaices Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H193 - H201. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dostanic, R. J. Paul, J. N. Lorenz, S. Theriault, J. W. Van Huysse, and J. B. Lingrel The {alpha}2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H477 - H485. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. Iwai, L. Wu, T. Shiuchi, T. Jinno, T.-X. Cui, and M. Horiuchi Role of AT2 receptor in the brain in regulation of blood pressure and water intake Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H116 - H121. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Rossoni, M. Salaices, M. Miguel, A. M. Briones, L. A. Barker, D. V. Vassallo, and M. J. Alonso Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2110 - H2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lanfranchi and V. K Somers Arterial baroreflex function and cardiovascular variability: interactions and implications Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R815 - R826. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Dmitrieva and P. A. Doris Cardiotonic Steroids: Potential Endogenous Sodium Pump Ligands with Diverse Function Experimental Biology and Medicine, September 1, 2002; 227(8): 561 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang and F. H. H. Leenen AT1 receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1318 - H1323. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |